Skip to content

Evaluation of Acclimate Feature for Positive Airway Pressure (PAP) Therapy

Evaluation of Positive Airway Pressure (PAP) Feature to Improve Patient Adherence to Therapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01421654
Enrollment
20
Registered
2011-08-23
Start date
2011-09-30
Completion date
2011-12-31
Last updated
2013-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

OSA, Sleep Apnea, PAP, positive airway pressure

Brief summary

The purpose of the study is to evaluate if using the Acclimate feature at the beginning of Positive Airway Pressure (PAP) therapy results in patients using their PAP therapy at least as long as they would standard therapy. Additionally, the Acclimate feature will be evaluated with regard to patient comfort, ease of acceptance of PAP therapy, leak events, and respiratory events.

Detailed description

Acclimate has been designed as a comfort feature for patients starting PAP therapy. The feature allows acclimatization to the targeted positive airway pressure setting. Using the Acclimate feature, the pressure increases incrementally over a period of time. The feature can be only be used for a set period of time, afterwards which the device initiates the therapeutic session at the prescribed pressure.

Interventions

DEVICES9 Elite with Acclimate

S9 Elite Flow Generator with Acclimate feature activated

DEVICES9 Elite

S9 Elite Flow Generator

Sponsors

ResMed
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects ≥18 years of age. * Recent diagnosis of moderate to severe OSA where fixed PAP is clinically indicated. * Naïve to PAP therapy.

Exclusion criteria

* Patients requiring supplemental oxygen. * Patients with a history of pneumothorax, pneumomediastinum, cavities or cysts in the lung. * Previous surgery to the brain, middle or inner ear, pituitary gland or sinuses. * Middle ear infection or perforated ear drum. * Ongoing sinus infection/sinusitis. * Clinically significant epistaxis. * Predominant central sleep apneas in the subject's PSG.

Design outcomes

Primary

MeasureTime frameDescription
Hours Used30 daysThe number of hours that each group used the device will be compared between subjects using fixed pressure with the Acclimate mode and subjects using fixed pressure without the Acclimate mode.

Countries

United States

Participant flow

Recruitment details

The study was conducted at one (1) clinical site in the US. The first subject was consented 06Sept2011 (Subject 01) and the last subject consented on 23Nov2011 (Subject 23).

Participants by arm

ArmCount
Fixed Mode + Acclimate
S9 Elite flow generator with Acclimate feature activated.
11
Fixed Mode Only
S9 Elite Flow Generator with Fixed Mode only
9
Total20

Baseline characteristics

CharacteristicFixed Mode OnlyFixed Mode + AcclimateTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants1 Participants4 Participants
Age, Categorical
Between 18 and 65 years
6 Participants10 Participants16 Participants
Age Continuous58.5 years
STANDARD_DEVIATION 9.2
52.3 years
STANDARD_DEVIATION 11.2
55.1 years
STANDARD_DEVIATION 10.1
Region of Enrollment
United States
9 participants11 participants20 participants
Sex: Female, Male
Female
4 Participants5 Participants9 Participants
Sex: Female, Male
Male
5 Participants6 Participants11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 110 / 10
serious
Total, serious adverse events
0 / 110 / 10

Outcome results

Primary

Hours Used

The number of hours that each group used the device will be compared between subjects using fixed pressure with the Acclimate mode and subjects using fixed pressure without the Acclimate mode.

Time frame: 30 days

ArmMeasureValue (MEAN)Dispersion
Fixed Mode + AcclimateHours Used146.9 Total Hours UsedStandard Deviation 62.9
Fixed Mode OnlyHours Used141.9 Total Hours UsedStandard Deviation 64.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026